about
Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian CancerRandomized Phase II Study of Intraperitoneal Versus Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian CancerLenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerIdentifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal CancerIntraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal CavityVaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancersCarboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerPh II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary AdenocarcinomaAllogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal CancerTopotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal CancerHyperthermic Intraperitoneal Oxaliplatin for Peritoneal MalignanciesEffect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal CancerDocetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity CancerOVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian CancerCarboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerCombination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerLapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or CarboplatinDocetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic CancerTopotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerOutcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative MedicineGemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal CancerDocetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity CancerGemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerErlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerGene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal CancerEffect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial CancerLurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial CancerS9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in RemissionErlotinib and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerS0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian CancerIxabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerOctreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by SurgeryComparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerS0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian CancerOxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCombination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal CancerDocetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal CancerS9912 Combination Chemo in Stage III Ovarian Cancer,Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer
P921
Q64042530-CD76F01F-8E7F-45E6-8687-B2B57B105E56Q64661090-3AFF8767-C6B8-43EC-A040-4BB732C148EAQ64675934-A116AF31-AF09-48EC-A9C8-719609005E74Q64676372-4AB28AE1-CA68-4340-BE39-C454B1848736Q64694392-0554E8F6-F315-485E-9F0A-CFB507B71F9EQ64708845-C9A2393C-07E9-4D3C-A2C4-2B56D031B4A8Q64716962-7F9D2EFF-32BE-49C6-87B2-73858D7E5B38Q64720176-3F179D4F-0A84-43CD-BD2E-50E40D958FB4Q64720244-DBAC7CBA-A254-4414-9E21-9281C10C3AB3Q64720277-92E1FCC9-1236-41AD-9D6A-089BB21FB6C7Q64722227-7591079B-0E10-4B14-B64F-4C9DDCF7D0EEQ65380966-56145DBF-57EC-42A9-BD69-920732EDB89CQ65387265-8E49945D-5D61-46DC-8246-D2385B4231FAQ65387716-CC18A687-1B1B-4728-9999-F69F106F4B9CQ65390644-68AA9406-BC36-4DE5-9606-979865BD3CCFQ65471217-9520C976-ACAC-4795-A7C4-D10A01D74C0DQ65472588-3B9A9081-947B-4C32-9F92-1C8506E76217Q65537404-6E92A7DC-A72F-4481-8A6B-A1B346B7B4C7Q65537407-E6831B48-4D2B-4942-A9DB-0F3FD502D9EEQ65538573-34873EE5-AA4E-48C5-B669-EB2C129FFE3BQ65542971-5375554C-8020-4BE8-A212-A30131706003Q65544477-1FF43DC1-A1C4-49ED-9C40-7BBA9D6738CBQ65544479-C5160085-8138-4E71-9DCE-2F9D22CFCD25Q65544483-B64FD31A-0921-4E31-B14F-ABE40835D868Q66033944-4B4D845E-EF2C-4973-935F-DF67A0E7099BQ66034487-C8CB6D90-90DA-4366-B421-956EEA5BFB6EQ66034922-30FB0934-D3F9-4756-A1D4-EBBC4B5D971CQ66035029-CFCF4F1A-EB8B-4B99-A0E1-0A0A4034C797Q66035822-70080DDB-B6CA-439E-89A6-289167158A90Q66035928-36E27D44-1C0D-41BA-869F-82733EAE63FAQ66036344-65469F71-7044-45BB-A8F3-9B56A99AF8D9Q66036384-2D0609AC-68D6-4587-95E3-59428518CF19Q66036459-0B617A09-731C-42CD-9011-8922FDEC2956Q66037280-F8132582-9535-4C33-825A-346D4293E449Q66037367-212885C5-9665-4062-9A6E-03381E69A7AEQ66037735-BF7058B7-8F80-403A-9B32-2F43B71042C9Q66037882-0080AF01-7958-4A58-B2F7-3C08D38EF080Q66037942-1023BF55-DC50-4A8E-9E58-0FBFE6430204Q74131869-E2B0DB12-D0D3-4533-A150-03E0105B5003
P921
description
Krankheit
@de
organ system cancer that is located in the peritoneum
@en
مرض يصيب الإنسان
@ar
name
cancer du péritoine
@fr
peritoneum cancer
@en
سرطان البريتون
@ar
腹膜の悪性腫瘍
@ja
type
label
cancer du péritoine
@fr
peritoneum cancer
@en
سرطان البريتون
@ar
腹膜の悪性腫瘍
@ja
altLabel
Cancer of the Peritoneum
@en
Malignant Peritoneal Neoplasm
@en
Peritoneal Cancer
@en
Peritoneal Cavity Cancer
@en
cancer of peritoneum
@en
malignant neoplasm of peritoneum
@en
malignant peritoneum neoplasm
@en
peritoneal neoplasm
@en
prefLabel
cancer du péritoine
@fr
peritoneum cancer
@en
سرطان البريتون
@ar
腹膜の悪性腫瘍
@ja
P1692
P2176
P2892
P1692
P1748
P1995
P2892
P31
P4229
P5270
MONDO:0002087